期刊文献+

铜陵地区大肠埃希菌和克雷伯菌属ESBLs检测及耐药性分析 被引量:14

Detection of extended-spectrum beta-lactamases and resistance in Escherichia coli and Klebsiella isolates in Tongling area
下载PDF
导出
摘要 目的了解安徽省铜陵地区大肠埃希菌和克雷伯菌属产ESBLs的检出率及其耐药状况。方法铜陵地区2003年1月-2004年12月临床分离大肠埃希菌270株和克雷伯菌属127株用NCCLS表型确证试验(纸片增强法)检测其ESBLs产生率;并用Kirby-Bauer法进行药敏试验。结果大肠埃希菌和克雷伯菌属ESBLs产生率分别为37.8%和30.7%;产ESBLs株对亚胺培南均呈敏感,对头孢西丁、头孢哌酮-舒巴坦及哌拉西林-三唑巴坦耐药率较低,对其他抗菌药物的耐药率均较不产ESBLs株高。结论临床上应加强细菌耐药性监测及ESBLs检测,指导临床合理使用抗菌药物,防止产ESBLs菌株的产生和流行。 Objective To investigate the resistance and extended-spectrum β-lactamases (ESBLs) in E. coli and Klebsiella isolates, which were isolated from January 2003 to December 2004 in Tongling area. Methods ESBLs production was detected by NCCLS phenotypic confirmatory test in E. coli (n = 270) and Klebsiella (n = 127) isolates. Antimicrobial susceptibility was tested by Kirby-Bauer method. Results The prevalence of ESBLs was 37.8% in E. coli and 30.7% in Klebsiella isolates. All ESBLs producing strains in our study were susceptible to imipenem, and relatively susceptible to cefoxitin, cefoperazone-sulbactam and piperacillin-tazobactam. ESBLs-producers had much higher resistance rates to other antimicrobial agents compared with ESBLs non-producing strains. Conclusions Surveillance of resistance and ESBLs detection are of great importance to both rational use of antibiotics and control of ESBL producers.
出处 《中国感染与化疗杂志》 CAS 2006年第2期116-118,共3页 Chinese Journal of Infection and Chemotherapy
基金 安徽省铜陵市科技计划项目经费资助课题(项目编号02A2222)
关键词 大肠埃希菌 克雷伯菌属 超广谱Β内酰胺酶 耐药性 抗菌药物 Escherichia coli Klebsiella Extended-spectrum beta-lactamases Antibiotic resistance Antimicrobial agent
  • 相关文献

参考文献8

二级参考文献45

  • 1魏衍超,肖柯玲,王敏玲,叶婷,陈曼妮.肺炎克雷伯菌和大肠埃希菌超广谱β-内酰胺酶检测与分析[J].广州医学院学报,2001,29(4):52-56. 被引量:1
  • 2刘正群.大肠埃希菌、肺炎克雷伯菌产超广谱β—内酰胺酶检测[J].上海医学检验,1999,14(5):271-271.
  • 3Sirot D. Extended-spctrnm plasmid-mediatad β-laotamases [J]. J Antimicrob Chemother , 1996,36(suppl) :s19-34.
  • 4Philippon A, Labia R, Jacoby G, Extended-spectrum betalactam ases [J]. Antibimicrob Agents Chemother , 1989,33(8): 1131.
  • 5Medeiros AA. Evolution and dissemination of bete-lacta-mases acceleraeed by generation beta-lactam antibiotics [J]. Clim Infect Dis , 1997,24(suppl):s19-45.
  • 6Jacoby GA, Han P. Detection of extended-spectrum beta lactam ases in clin ical isolates of Klebsiella Pneumoniae and Escherichiacoli [J]. J Clin Microbiol , 1996,34(4):908.
  • 7Jacoby G A,Medeiros A A.More extended- spectrum beta- lactamases[J].Antimicrob Agents Chemother,1991,35(9):1697
  • 8National Committee for Clinical Laboratory Standards.Perfor- mance standards for antimicrobial susceptibility testing. 9th informational supplemented[S].Wayne PA:National Committee for Clinical Laboratory Standards,1999
  • 9National Committee for Clinical Labortory Standards for antimicrobial susceptibility testing[M].Ninth informational standards.Performance Standards M100-S9.Pennsylvania: NCCLS, 1999.1-103.
  • 10Craig WA. Pharmacokinetic/Pharmacyodynamic parameters:rationale for antibacterial dosing of mice and men[J]. Clin Infect Dis, 1998,26:1-10.

共引文献403

同被引文献66

引证文献14

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部